Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Aigner

Showing results (191-200 of 296) with videos related to

Pageof 30
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|June 1, 2026
What Is Possible for Patients After Lung Transplantation? The Highest Reported Altitude Achieved by a Lung Transplant Recipient Without Supplemental Oxygen - Climbing Mount Aconcagua (6.961m)Jakob Mühlbacher, Alexis Slama, Konrad Hoetzenecker, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2019
Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patientsVasiliki Bessa, Ming Sun, Maike Meier, et al.
Cancer & Metabolism|April 1, 2025
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylationAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Thoracic Cancer|March 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural MesotheliomaBerta Mosleh, Stefan Schwarz, Anna Cho, et al.
British Journal of Cancer|September 4, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesotheliomaKarin Schelch, Nadine Maach, Muhammad Hashim, et al.
Pathology Oncology Research : POR|June 28, 2020
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell LineLuca Hegedűs, Dominika Rittler, Tamás Garay, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2025
Using <sup>18</sup>F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancerZewen Jiang, David Haberl, Clemens Spielvogel, et al.
JHLT Open|October 13, 2025
CD38-targeted therapy with Daratumumab in clinical lung transplantation: A single-center experienceCaroline Hillebrand, Giuseppe Maggioni, Sophia Auner, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improveNika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Biomarker Research|June 26, 2026
Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPDAyu Hutami Syarif, Bernhard F E Reiter, Alexander Avian, et al.
Pageof 30

Showing results (191-200 of 296) with videos related to

Sort By:
Pageof 30
Transplant International : Official Journal of the European Society for Organ Transplantation|June 1, 2026
What Is Possible for Patients After Lung Transplantation? The Highest Reported Altitude Achieved by a Lung Transplant Recipient Without Supplemental Oxygen - Climbing Mount Aconcagua (6.961m)Jakob Mühlbacher, Alexis Slama, Konrad Hoetzenecker, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2019
Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patientsVasiliki Bessa, Ming Sun, Maike Meier, et al.
Cancer & Metabolism|April 1, 2025
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylationAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Thoracic Cancer|March 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural MesotheliomaBerta Mosleh, Stefan Schwarz, Anna Cho, et al.
British Journal of Cancer|September 4, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesotheliomaKarin Schelch, Nadine Maach, Muhammad Hashim, et al.
Pathology Oncology Research : POR|June 28, 2020
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell LineLuca Hegedűs, Dominika Rittler, Tamás Garay, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2025
Using <sup>18</sup>F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancerZewen Jiang, David Haberl, Clemens Spielvogel, et al.
JHLT Open|October 13, 2025
CD38-targeted therapy with Daratumumab in clinical lung transplantation: A single-center experienceCaroline Hillebrand, Giuseppe Maggioni, Sophia Auner, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improveNika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Biomarker Research|June 26, 2026
Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPDAyu Hutami Syarif, Bernhard F E Reiter, Alexander Avian, et al.
Pageof 30